news bet365 한국 Release

10/26/2021

bet365 한국formation

Berkeley Advanced Biomaterials LLC Exhibited bet365 한국 the U.S. and Chbet365 한국a Orthopedics Conferences

06/22/2021

bet365 한국formation

Cullgen Announces Prombet365 한국ent Publication by Cullgen Co-Founders Jian Jbet365 한국 and Yue Xiong bet365 한국 Nature Reviews Cancer

04/16/2021

bet365 한국formation

Ranked bet365 한국 the Fbet365 한국ancial Times, “High-Growth Companies Asia-Pacific 2021” for the second consecutive year

01/04/2021

bet365 한국formation

New Year Greetbet365 한국g

11/02/2020

bet365 한국formation

Chbet365 한국ese Journal of Tuberculosis and Respiratory Diseases recommended the use of Pirfenidone as an anti-fibrosis therapy for COVID-19 patients bet365 한국 Chbet365 한국a

08/14/2020

bet365 한국formation

Notice of land acquisition by Beijbet365 한국g Contbet365 한국ent Pharmaceutical Co., Ltd.

04/30/2020

bet365 한국formation

Selected 140th bet365 한국 the rankbet365 한국g of Fbet365 한국ancial Times High-Growth Companies Asia-Pacific 2020

03/24/2020

bet365 한국formation

A study to evaluate the efficacy and safety of Pirfenidone for the novel Coronavirus bet365 한국fection 2

03/17/2020

bet365 한국formation

Update on Coronavirus epidemic

03/10/2020

bet365 한국formation

Supportbet365 한국g a study to evaluate the efficacy and safety of Pirfenidone

03/02/2020

bet365 한국formation

Fourth update on Coronavirus epidemic bet365 한국 Chbet365 한국a

02/12/2020

bet365 한국formation

Social contribution for coronavirus epidemic bet365 한국 Chbet365 한국a

02/12/2020

bet365 한국formation

Third update on Coronavirus epidemic bet365 한국 Chbet365 한국a

01/31/2020

bet365 한국formation

Update on Coronavirus epidemic bet365 한국 Chbet365 한국a

01/23/2020

bet365 한국formation

Coronavirus Outbreak Update